Electromagnetic and Weak Nuclear Structure Functions F1,2(x,Q2)F_{1,2}(x,Q^2) in the Intermediate Region of Q2Q^2

We have studied nuclear structure functions $F_{1A}(x,Q^2)$ and $F_{2A}(x,Q^2)$ for electromagnetic and weak processes in the region of $1 GeV^2 < Q^2 <8 GeV^2$. The nuclear medium effects arising due to Fermi motion, binding energy, nucleon correlations, mesonic contributions and shadowing effects are taken into account using a many body field theoretical approach. The calculations are performed in a local density approximation using a relativistic nucleon spectral function. The results are compared with the available experimental data. Implications of nuclear medium effects on the validity of Callan-Gross relation are also discussed.Comment: Published in Journal of the Physical Society of Japan (NuInt-2015

Nucleon and nuclear structure functions with non-perturbative and higher order perturbative QCD effects

We have studied the nucleon structure functions $F_{iN}^{EM} (x,Q^2);~i=1,2$, by including contributions due to the higher order perturbative QCD effect up to NNLO and the non-perturbative effects due to the kinematical and dynamical higher twist (HT) effects. The numerical results for $F_{iN}^{EM}(x,Q^2)$ are obtained using Martin, Motylinski, Harland-Lang, Thorne (MMHT) 2014 NLO and NNLO nucleon parton distribution functions (PDFs). The dynamical HT correction has been included following the renormalon approach as well as the phenomenological approach and the kinematical HT effect is incorporated using the works of Schienbein et al. These nucleon structure functions have been used as an input to calculate the nuclear structure functions $F_{iA}^{EM} (x,Q^2)$. In a nucleus, the nuclear corrections arise because of the Fermi motion, binding energy, nucleon correlations, mesonic contribution, shadowing and antishadowing effects. These nuclear corrections are taken into account in the numerical calculations to obtain the nuclear structure functions $F_{iA}^{EM} (x,Q^2)$, for the various nuclear targets like $^{12}C$, $^{27}Al$, $^{56}Fe$, $^{64}Cu$, $^{118}Sn$, $^{197}Au$ and $^{208}Pb$ which are of experimental interest. The effect of isoscalarity correction for nonisoscalar nuclear targets has also been studied. The results for the $F_{iA}^{EM} (x,Q^2)$ are compared with nCTEQ nuclear PDFs parameterization as well as with the experimental results from JLab, SLAC and NMC in the kinematic region of $0.1 \le x \le 0.8$ for several nuclei.Comment: arXiv admin note: text overlap with arXiv:1705.0990

Cancer Patterns in Karachi Division (1998-1999)

Objective: A minimal cancer incidence data for Karachi, the largest city of Pakistan, is being presented here, for the years 1998-1999. The city has a population of 9,802,134; males 5,261,712 (52.6%) and females 4,540,422 (47.4%); census 19981. Methodology: A predominantly mixed (passive and active) registration system has evolved in Karachi, the data sources being the hospitals within the Karachi Division. The reported/retrieved cancer data sets at the Karachi Cancer Registry are checked, coded, computerised in an analytical format and analysed. Results: The incident cancer cases registered in Karachi, during the 2-year period, 1st January 1998 to 31st December 1999 were analysed. The age-standardised incidence rate (ASR) of cancer, all sites was 132.4/100,000 for the males. Cancer of the lung 10.8%; ASR 17.3 was the most frequently recorded malignancy, followed by oral cavity 10.5%; ASR 13.2 and larynx 5.0%; ASR 7.4. The age-standardised incidence rate (ASR) of cancer, all sites was 133.0/100,000 in the females. Cancer of the breast, 32.0%; ASR 40.7 was the most frequently recorded malignancy, followed by oral cavity 8.1%; ASR 11.7 and gall bladder 3.6%; ASR 5.5. Conclusion: The present data has been calculated with an estimated 15-20% probable under ascertainment. Tobacco-associated cancers in Karachi were responsible for 38.3% of the tumours diagnosed amongst the males. Two principal cancers, breast and oral cavity were responsible for 40.1% of the cancers in females. A rare finding was the high incidence of gall bladder cancer in the females. At present it is difficult to determine whether this indicates a genuine high risk or a selection bias. A continuous process of cancer registration to study the trends in the incidence and an adequate cancer control program are possible and essential for Pakistan and can be based on the pattern being practiced in Karachi

Pneumatosis Intestinalis in COVID-19: Case Series.

OBJECTIVE:To describe the clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) who developed pneumatosis intestinalis (PI). METHODS:This case series was conducted in intensive care units at two large tertiary care centers within the Northwell Health System, located in New York State. Patients were included if they were identified as having confirmed COVID-19 as well as pneumatosis intestinalis from March 16, 2020 to July 31, 2020. Patient demographics, clinical characteristics, vasopressor use, anticoagulation use, opiate use, paralytic use, COVID-19 treatment regimen, serum lactate, arterial pH, serum bicarbonate, subsequent intervention, and outcomes during hospitalization were collected. Results: A total of nine patients were identified. Average serum lactate was 4.33 mmol/L at time of diagnosis. Portal venous gas (56%) and bowel dilation (56%) were common radiographic findings. Subsequent morbidity (increased vasopressor requirements - 67%, acute kidney injury - 67%, increased oxygen requirements - 44%) and mortality (78%) were high. PI occurred despite a majority of patients being on anticoagulation (78%). Interleukin-6 (IL-6) inhibitors were commonly administered (56%) prior to development of PI. CONCLUSION:Pneumatosis intestinalis in COVID-19 is clinically significant, with high morbidity and mortality, and is also likely underdiagnosed

Standard Splenic Volume Estimation in North Indian Adult Population: Using 3D Reconstruction of Abdominal CT Scan Images

A prospective study was carried out to establish normative data for splenic dimensions in North Indian population and their correlation with physical standard on abdominal CT of 21 patients aged between 20 and 70 years having no splenic disorders. Splenic volume was measured by two methods—volume and surface rendering technique of Able 3D doctor software and prolate ellipsoid formula. Volumes measured by both the techniques were correlated with their physical standards. Mean splenic volume was 161.57 ± 90.2 cm3 and range 45.7–271.46 cm3. The volume of spleen had linear correlation with body height (r = 0.512, P < .05). Splenic volume (cm3) = 7 × height (cm) − 961 can be used to generate normal standard volume of spleen as a function of body height in North Indian population (with 95% confidence interval). This formula can be used to objectively measure the size of the spleen in adults who have clinically suspected splenomegaly